What is the recommended dose of Septra (trimethoprim/sulfamethoxazole) for a pediatric patient weighing 17 kilograms with normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Septra Dosing for a 17 kg Pediatric Patient

For a 17 kg child with normal renal function, administer Septra at 8 mg/kg/day of the trimethoprim component (68 mg trimethoprim/340 mg sulfamethoxazole per day) divided into two doses every 12 hours for treatment of common infections like urinary tract infections or acute otitis media. 1

Treatment Dosing by Weight

For standard infections (UTI, acute otitis media, shigellosis):

  • A 17 kg child falls between the 10 kg and 20 kg weight categories in FDA dosing tables 1
  • The FDA-approved dosing is 40 mg/kg/day sulfamethoxazole and 8 mg/kg/day trimethoprim, divided every 12 hours 1
  • For this 17 kg patient, this equals approximately 136 mg trimethoprim and 680 mg sulfamethoxazole per day, or 68 mg/170 mg per dose 1

Practical Tablet Dosing

  • The closest practical dose using standard tablets would be 1 single-strength tablet (80 mg trimethoprim/400 mg sulfamethoxazole) every 12 hours, which slightly exceeds the calculated dose but remains within safe parameters 1
  • Alternatively, liquid formulation allows more precise dosing and is recommended for children under 20 kg 2

Indication-Specific Dosing Variations

For Pneumocystis Jiroveci Pneumonia (Treatment)

  • Use 15-20 mg/kg/day trimethoprim (75-100 mg/kg/day sulfamethoxazole) divided every 6 hours for 14-21 days 3, 1
  • For this 17 kg child: 255-340 mg trimethoprim per day (51-68 mg every 6 hours) 3

For PCP Prophylaxis

  • Use 150 mg/m²/day trimethoprim with 750 mg/m²/day sulfamethoxazole divided into two doses, given 3 consecutive days per week 4, 2
  • This is the CDC-recommended regimen for immunocompromised children 4

For MRSA Infections

  • Use 4 mg/kg/dose of trimethoprim component every 8-12 hours, typically combined with rifampin 3, 5
  • For this 17 kg child: 68 mg trimethoprim per dose every 8-12 hours 5

Critical Dosing Considerations

Renal Function Adjustments

  • With creatinine clearance >30 mL/min: use standard dosing 5, 1
  • With creatinine clearance 15-30 mL/min: reduce to 50% of usual dose 5, 1
  • With creatinine clearance <15 mL/min: Septra is not recommended 5, 1

Monitoring Requirements

  • Obtain complete blood count with differential and platelet count at initiation 2, 5
  • For prophylactic therapy, repeat CBC monthly to detect hematologic toxicity 2, 5
  • Approximately 15% of children experience substantial adverse reactions including rash, gastrointestinal disturbances, and hematologic abnormalities 3, 4

Common Pitfalls to Avoid

  • Do not use Septra in children under 2 months of age—it is contraindicated 1
  • Liquid formulation provides more accurate dosing than tablets for children weighing less than 20 kg 2
  • Recent pharmacokinetic data suggests that 8 mg/kg/day trimethoprim divided every 12 hours achieves appropriate exposure matching adult dosing and targets bacteria with MIC ≤0.5 mg/L in >90% of children 6
  • Test doses are not recommended when initiating Septra therapy 2

References

Guideline

Bactrim Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prophylaxis with Septran DS in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Septran Dosing Guidelines in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.